Indikation: Diabetes - Typ II Clinical Trials
A listing of Indikation: Diabetes - Typ II medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 23 clinical trials
Do you have TYPE 2 DIABETES and have NEVER used insulin?
You can identify as potentially eligible for a clinical trial for the treatment of Type 2 Diabetes. The study compares the efficacy and safety of a weekly insulin compared to insulin glargine daily therapy. Medical care and study medications would be provided at no cost. Is this something you would …
- 0 views
- 03 Feb, 2023
- 1 location
Are you taking BASAL INSULIN to treat your TYPE 2 Diabetes?
The COMBINE 1 study is a long-term study comparing efficacy and safety of two new injectable investigational medicines for the treatment of Type 2 Diabetes. This study is part of a global program of clinical studies investigating how well a new investigational combination product taken once-weekly (IcoSema) affects blood sugar …
- 7 views
- 08 Dec, 2022
- 1 location
If you are living with OVERWEIGHT or OBESITY, then the REDEFINE 2 study may be for you
If you are living with overweight or obesity, then the REDEFINE 2 study may be for you. This study investigates the effect of an investigational medicine on weight loss.
- 55 views
- 03 Feb, 2023
- 1 location
Has Diabetes Affected Your Life?
Be part of a new approach to Diabetes care! AMCR Institute is currently recruiting for clinical trials to evaluate medical devices and investigational medications for pediatric and adult individuals with Type 1, Type 2 Diabetes, and obesity. AMCR Institute's team is committed to providing superior service to our volunteers and …
- 7 views
- 29 Nov, 2022
- 1 location
A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of MK-5475 in Adults With Pulmonary Arterial Hypertension
This is a two-part (Phase 2/Phase 3) study of MK-5475, an inhaled soluble guanylate cyclase stimulator, in participants with pulmonary arterial hypertension (PAH). The first part (Phase 2) will assess three different doses of MK-5475 compared to placebo in a base period of 12 weeks, followed by comparison of three …
- 38 views
- 20 Oct, 2022
- 76 locations
The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension (AFR-Prophet)
This study aims to investigate safety and efficacy of Occlutech® AFR device in patients with severe pulmonary hypertension (PH).
- 46 views
- 07 Oct, 2022
- 12 locations
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group, Event-Driven, Group-Sequential Study With Open-Label Extension Period to Assess the Efficacy and Safety of Selexipag as Add-On Treatment to Standard of Care in Children Aged >=2 to <18 Years With Pulmonary Arterial Hypertension (SALTO)
The purpose of this study is to evaluate whether the addition of selexipag to standard of care treatment delays disease progression in children with Pulmonary Arterial Hypertension (PAH) in comparison to placebo.
- 247 views
- 25 Oct, 2022
- 84 locations
A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH (CAPACITY)
Study ROR-PH-302, ADVANCE CAPACITY, is designed to evaluate the effects of ralinepag therapy on exercise capacity as assessed by change in peak oxygen consumption (VO2) derived from cardiopulmonary exercise testing (CPET) after 28 weeks of treatment
- 4 views
- 04 Oct, 2022
- 36 locations
An Open-label, Multi-national, Multi-center, Single-arm, Uncontrolled, Long-term Extension Study of Orally Administered Riociguat in Patients With Symptomatic Pulmonary Arterial Hypertension (PAH) Who Received Riociguat in a Bayer Clinical Trial (RIALTO)
To provide riociguat therapy to eligible patients with PAH originating from Bayer-sponsored trials with BAY63-2521/ Riociguat / Adempas® who are currently or recently treated in these trials until lack of patient benefit as assessed by investigator, or commercial availability and reimbursement.
- 2 views
- 24 Oct, 2022
- 1 location
Training Single Arm
The pulmonary hypertension is a disease, which tends to a progredient right heart failure. Although there was a large progress in development of medical therapy, the quality of life, the physical efficiency and the prognosis of the patients are still limited. The aim of the study is to examine the …
- 1 views
- 04 Oct, 2022
- 1 location